title: [Bone and Nutrition. Nutrition care of renal osteodystrophy].
abstract: Renal osteodystrophy is the damage of bone morphology by CKD and treatment and occurred abnormal bone metabolism through renal dysfunction. It demonstrated that the control of P and Ca improves to normalization of mineral metabolism. Protein energy wasting and malnutrition are common in patients with CKD stage 5 and has been associated with life prognosis. In CKD patients, nutritional management is a critical role of treatment. Also it may be important of nutritional management that control P and Ca and improve nutritional status in renal osteodystrophy patients.
authors.affiliation: Graduate school of Human Science and Environment, University of Hyogo, Japan.
authors.forename: Sarasa
authors.initials: S
authors.lastname: Tanaka
authors.forename: Mikiko
authors.initials: M
authors.lastname: Ito
mesh_terms: D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002762:Cholecalciferol / Q000008:administration & dosage; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D004164:Diphosphonates / Q000008:administration & dosage; D006801:Humans; D044623:Nutrition Therapy / Q000379:methods; D009752:Nutritional Status; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D010758:Phosphorus / Q000378:metabolism; D011379:Prognosis; D011502:Protein-Energy Malnutrition / Q000209:etiology / Q000517:prevention & control; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy
chemical_list: D004164:Diphosphonates; D002762:Cholecalciferol; D010758:Phosphorus; D002118:Calcium